Article
TP53 loss‐of‐function causes vulnerability to autophagy inhibition in aggressive prostate cancer
17 Aug 2022
Abstract excerpt
OBJECTIVES: TP53 loss-of-function is commonly found in aggressive prostate cancer. However, a highly-efficient therapy for this tumor subtype is still lacking. In this study, we investigated the relationship between TP53 mutation status and autophagy in prostate cancer and assessed the efficacy of autophagy inhibitors on TP53-deficient tumors. METHODS: We first evaluated the expression patterns of p53 and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
